To do this, they examined the brain tissue of 205 patients with glioblastoma to see if there were signs of Alzheimer’s disease, (beta-amyloid, amyloid precursor protein, and tau). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.